Clinical trial
Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy
NCT02903368
Study timeline
Study start (actual)2016-10-19Date precision: day
Registry last updated2025-06-13
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Cancerunresolved
Interventions
ApalutamideDRUG · verified · RxNorm: apalutamide
LeuprolideDRUG · verified · RxNorm: leuprolide
PrednisoneDRUG · verified · RxNorm: prednisone
Abiraterone AcetateDRUG · verified · RxNorm: abiraterone acetate
Sponsors & collaborators
Dana-Farber Cancer Institutelead sponsor
Janssen Scientific Affairs, LLCcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02903368 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.